Bitcoin ETFs Record First Half-Year of Net Outflows

4 hours ago
Lacey@GCS

Bitcoin spot exchange-traded funds posted their first negative six-month performance since entering the market, marking a notable shift after a…

VERAXA Biotech AG (NASDAQ: VRXA) Advances Lead BiTAC(R) T-Cell Engager Program with Cell Line Development Partnership

1 day ago

The company has initiated cell line development for its lead BiTAC(R) T-cell engager program, selecting ATUM to support manufacturing development…

France to Relaunch its Social Leasing EV Program in July

2 days ago

France will relaunch the country’s social leasing electric vehicle (EV) program on July 16, 2026 as part of its effort…

South Korea Earmarks $1 Trillion for Chip, AI Investment

3 days ago

South Korea has announced one of its biggest technology investment plans ever. The country plans to spend more than $1…

Why Wall Street Watches Jefferies’ Earnings Reports Closely

1 week ago

Jefferies Financial may not be as large as Wall Street giants like Goldman Sachs, Morgan Stanley, or JPMorgan Chase, but…

Why VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Pay Serious Attention to Antibody Therapeutics Sector Deals

1 week ago

Deal activity remains strong in antibody-drug conjugates (ADCs) and T-cell engager (TCE) therapeutics, with pharmaceutical companies continuing to commit substantial…

China-Made Sodium Battery Surprisingly Matches Tesla Battery Standards

1 week ago

A new study has revealed that a sodium-ion battery made by Chinese manufacturer Hina has achieved performance levels that are…

Money Seems to Be Shifting from Bitcoin to XRP

2 weeks ago

Money in the crypto market often moves in patterns that can look dramatic at first glance. Recently, ETF flow data…

EU Considers Imposing Tariffs on Chinese PHEVs

2 weeks ago

The European Union is reportedly considering new tariffs on plug-in hybrid electric vehicles (PHEVs) imported from China. The move comes…

VERAXA Biotech AG (NASDAQ: VRXA) Advances BiTAC-ADC Platform as It Expands Next-Generation Cancer Therapy Pipeline

2 weeks ago

VERAXA Biotech has reported new in vitro proof-of-concept data supporting its BiTAC-ADC technology, demonstrating selective activity against cancer cells while…